IRCT20180421039376N1
Completed
Phase 3
Escitalopram efficacy on quality of life and prevention of depression in breast cancer patient with mastectomy
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 75
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women 18\-65 y/o
- •Diagnosed with breast cancer stage I,II,IIIa and undergone modified radical mostectomy with or without chemothrapy and radiotherapy
- •Consciously agreement
- •Having at least literacy of writing and reading
Exclusion Criteria
- •Pregnancy and lactation
- •History of conductive heart diseases
- •Severe renal failure
- •Moderate to severe hepatic failure
- •History of SSRI drugs reactions and sensitivity
- •Suffering from depression mood disorders, bipolar disorders or psychotic disorders based on DSM V criteria
- •Any condition limiting life expectancy
- •Any Use of anti depression or anti anxiety drugs since 2 weeks before the study
- •Any precipitation on group or individual psychotherapy sessions since 4 weeks before the study
- •Suffering from any speech disorders
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
The effect of treatment with escitalopram on quality of life and hospitalization rate in depressed patients with systolic heart failureheart failure.Heart failureIRCT20230510058142N1Shahid Beheshti University of Medical Sciences84
Completed
Phase 4
A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety SymptomDepressive Disorder, MajorNCT01870843Xian-Janssen Pharmaceutical Ltd.261
Completed
Phase 2
Evaluation of the effect of Escitalopram versus placebo trial on changing the neuroticismeuroticism or neuroticism.Post-traumatic stress disorder, acuteF43.11IRCT20211208053331N1Ahvaz University of Medical Sciences172
Completed
Phase 3
Escitalopram ?s effectiveness on treatment of depressive disorder and improvement of quality of life in patients who are undergone coronary artery bypass graft surgeryIRCT20140126016374N2niversity of social welfare and rehabilitation sciences50
Completed
Phase 4
Comparison Of Two Anti Depressant Drugs In Major Depressive DisorderHealth Condition 1: null- Major Depressive DisorderCTRI/2018/02/011662Government Medical College50